• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌根除后萎缩性胃炎和肠化生的随访研究

A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori.

作者信息

Satoh K, Kimura K, Takimoto T, Kihira K

机构信息

Department of Gastroenterology, Jichi Medical School, Tochigi, Japan.

出版信息

Helicobacter. 1998 Dec;3(4):236-40.

PMID:9844064
Abstract

BACKGROUND

Opinions differ as to whether atrophic gastritis and intestinal metaplasia (IM) improve after Helicobacter pylori eradication. We investigated the change of the severity of atrophy and IM after H. pylori eradication.

MATERIALS AND METHODS

Twenty H. pylori-positive patients with histologically confirmed atrophic gastritis received anti-H. pylori therapy and achieved eradication. They were followed for 12-33 months (median 17 months) after the therapy. Biopsies were taken from the lesser and greater curvatures of the mid-antrum and middle body, and the incisura angularis of the stomach. The state of H. pylori infection was assessed histologically (Giemsa stain). Histological severity of atrophy and IM was graded according to the Updated Sydney System and scored on a 0-3 scale. The scores of atrophy and IM were compared between before and after the therapy (at the end of follow-up).

RESULTS

No significant difference was found in the scores of antral or body atrophy between before and after the therapy. Scores of antral IM increased after the therapy, whereas those of body IM did not change significantly. Development of IM in the whole stomach was found in three of seven patients who had no IM before the therapy. All of them were male smokers and drinkers. In contrast, complete regression of IM was not found.

CONCLUSIONS

Our results cast doubt on the reversibility of atrophy and IM after H. pylori eradication. Development of IM could be found in some of patients with atrophy even after H. pylori eradication.

摘要

背景

关于根除幽门螺杆菌后萎缩性胃炎和肠化生(IM)是否会改善,存在不同观点。我们研究了根除幽门螺杆菌后萎缩和IM严重程度的变化。

材料与方法

20例经组织学确诊为萎缩性胃炎的幽门螺杆菌阳性患者接受了抗幽门螺杆菌治疗并实现了根除。治疗后对他们进行了12 - 33个月(中位时间17个月)的随访。从胃窦中部和胃体中部的小弯侧和大弯侧以及胃角切迹处取活检组织。通过组织学检查(吉姆萨染色)评估幽门螺杆菌感染状态。根据更新的悉尼系统对萎缩和IM的组织学严重程度进行分级,并在0 - 3分的量表上评分。比较治疗前后(随访结束时)萎缩和IM的评分。

结果

治疗前后胃窦或胃体萎缩评分无显著差异。治疗后胃窦IM评分增加,而胃体IM评分无显著变化。在治疗前无IM的7例患者中,有3例出现了全胃IM。他们均为男性吸烟者和饮酒者。相反,未发现IM完全消退。

结论

我们的结果对根除幽门螺杆菌后萎缩和IM的可逆性提出了质疑。即使在根除幽门螺杆菌后,部分萎缩性胃炎患者仍可能出现IM。

相似文献

1
A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori.幽门螺杆菌根除后萎缩性胃炎和肠化生的随访研究
Helicobacter. 1998 Dec;3(4):236-40.
2
Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.幽门螺杆菌根除在萎缩性胃炎愈合中的作用:一项为期一年的前瞻性研究。
Scand J Gastroenterol. 2006 Jul;41(7):782-90. doi: 10.1080/00365520500463175.
3
Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea.预测幽门螺杆菌根除后萎缩性胃炎和肠上皮化生改善的因素:韩国一项为期 3 年的随访研究。
Helicobacter. 2012 Apr;17(2):86-95. doi: 10.1111/j.1523-5378.2011.00918.x.
4
Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?胃切迹、胃体和胃底的窦型黏膜(胃窦化):幽门螺杆菌感染与肠化生之间的联系?
Am J Gastroenterol. 2000 Jan;95(1):114-21. doi: 10.1111/j.1572-0241.2000.01609.x.
5
[The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].[根据胃黏膜炎症病变程度评估幽门螺杆菌感染患者胃液中一氧化氮代谢产物]
Pol Merkur Lekarski. 2008 Feb;24(140):95-100.
6
Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.根除幽门螺杆菌感染可改善胃黏膜萎缩,预防肠上皮化生进展,尤其在老年人群中:一项长期前瞻性队列研究。
J Gastroenterol Hepatol. 2010 Mar;25(3):544-7. doi: 10.1111/j.1440-1746.2009.05995.x. Epub 2009 Oct 6.
7
Impact of Helicobacter pylori eradication on the development of MALT, gland atrophy and intestinal metaplasia of the antrum.幽门螺杆菌根除对胃黏膜相关淋巴组织淋巴瘤(MALT)的发生、胃窦腺萎缩及肠化生的影响。
Zhonghua Yi Xue Za Zhi (Taipei). 2000 Apr;63(4):279-87.
8
Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis.幽门螺杆菌阳性和阴性慢性胃炎患者胃内炎症及萎缩的分布情况。
Am J Gastroenterol. 1996 May;91(5):963-9.
9
Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study.幽门螺杆菌根除与胃窦肠化生——两年随访研究
J Physiol Pharmacol. 1997 Sep;48 Suppl 4:115-22.
10
Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia.萎缩性胃炎和/或肠化生背景下幽门螺杆菌的检出率
J Clin Gastroenterol. 2007 Sep;41(8):751-5. doi: 10.1097/MCG.0b013e31802c347d.

引用本文的文献

1
Precancerous pathways to gastric cancer: a review of experimental animal models recapitulating the correa cascade.胃癌的癌前病变途径:对重现科雷亚级联反应的实验动物模型的综述
Front Cell Dev Biol. 2025 Jul 2;13:1620756. doi: 10.3389/fcell.2025.1620756. eCollection 2025.
2
Pathogenesis and potential reversibility of intestinal metaplasia - a milestone in gastric carcinogenesis.肠上皮化生的发病机制及潜在逆转 - 胃癌发生的一个里程碑。
Radiol Oncol. 2024 Apr 21;58(2):186-195. doi: 10.2478/raon-2024-0028. eCollection 2024 Jun 1.
3
Lamb's tripe extract and vitamin B capsule plus celecoxib reverses intestinal metaplasia and atrophy: A retrospective cohort study.
羊肚提取物、维生素B胶囊加塞来昔布可逆转肠化生和萎缩:一项回顾性队列研究。
World J Clin Cases. 2021 Dec 6;9(34):10472-10483. doi: 10.12998/wjcc.v9.i34.10472.
4
Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body.胃窦和胃体均检出时,肠化生进展的风险显著增加。
Dig Dis Sci. 2021 Oct;66(10):3470-3475. doi: 10.1007/s10620-020-06659-8. Epub 2020 Oct 23.
5
Population screening and treatment of Helicobacter pylori infection.人群筛查及幽门螺杆菌感染的治疗。
Nat Rev Gastroenterol Hepatol. 2017 Apr;14(4):230-240. doi: 10.1038/nrgastro.2016.195. Epub 2017 Jan 5.
6
Expression of CDX2 in gastric cardia adenocarcinoma and its correlation with H. pylori and cell proliferation.CDX2在贲门腺癌中的表达及其与幽门螺杆菌和细胞增殖的相关性。
Oncotarget. 2016 Aug 23;7(34):54973-54982. doi: 10.18632/oncotarget.10362.
7
Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study.胃化生和发育异常患者胃腺癌的风险与预测因素:一项基于人群的研究
Am J Gastroenterol. 2016 Aug;111(8):1104-13. doi: 10.1038/ajg.2016.188. Epub 2016 May 17.
8
The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes.胃黏膜肠化生的患病率及其亚型中幽门螺杆菌感染、萎缩、异型增生和癌症的分布情况。
Gastroenterol Res Pract. 2015;2015:434039. doi: 10.1155/2015/434039. Epub 2015 Nov 9.
9
Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population.胃癌前病变患者中胃癌的发病率:西方低风险人群的观察性队列研究
BMJ. 2015 Jul 27;351:h3867. doi: 10.1136/bmj.h3867.
10
Long-term monitoring of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication.幽门螺杆菌根除后胃萎缩和肠化生的长期监测
Clin J Gastroenterol. 2012 Aug;5(4):247-50. doi: 10.1007/s12328-012-0317-2. Epub 2012 Jun 17.